Valeant CEO Makes His Case Right to Analysts

The transcript discusses a company's canceled earnings call and subsequent private calls by the CEO with select analysts, which influenced stock prices. It also covers Hillary Clinton's campaign against drugmakers and questions about Michael Pearson's leadership in addressing the company's challenges.

What actions did the company take regarding the earnings call?

How did the stock react after the one-on-one calls with analysts?

What was Hillary Clinton's stance on drugmakers during her campaign?

What concerns do investors have regarding Michael Pearson's leadership?

What was the market's reaction to the SEC investigation mentioned?